Mar 11, 2026 12:45PM
Feb 5, 2026 11:45AM
Dec 2, 2025 11:45AM
Oct 23, 2025 11:45AM
Apr 21, 2025 04:05PM
Mar 26, 2025 12:45PM
Oct 12, 2023 11:57AM Guerbet: CHMP positive opinion
Mar 22, 2023 12:45PM
Feb 9, 2023 11:46AM
Nov 22, 2022 07:21PM
Oct 20, 2022 11:45AM
Oct 5, 2022 09:03AM
Sep 21, 2022 11:45AM
Sep 15, 2022 06:00PM GBT Supports the Sickle Cell Disease Treatment Centers Act of 2022
Sep 8, 2022 08:00AM
Aug 8, 2022 06:46AM
Aug 8, 2022 06:45AM
Aug 8, 2022 06:45AM
Aug 4, 2022 04:05PM
Aug 3, 2022 04:05PM
Jul 29, 2022 08:00AM GBT to Announce Second Quarter 2022 Financial Results on Monday, August 8, 2022
Jul 26, 2022 05:59AM
Jul 26, 2022 03:01AM
Jul 26, 2022 03:01AM
Jul 14, 2022 08:00AM
Jul 13, 2022 08:00AM
Jul 7, 2022 04:05PM
Jun 29, 2022 08:00AM GBT Initiates Phase 2/3 Clinical Trial of GBT601 in Patients with Sickle Cell Disease
Jun 16, 2022 08:00AM
Jun 13, 2022 08:00AM
Jun 13, 2022 08:00AM
Jun 10, 2022 05:34AM
Jun 10, 2022 03:00AM
Jun 10, 2022 03:00AM
Jun 6, 2022 10:00AM The GBT Foundation Opens 2022 ACCEL Grant Program to Provide Up to $500,000 in Support to Sickle Cell Disease Nonprofit Healthcare Organizations and Institutions
Jun 6, 2022 08:05AM
Jun 6, 2022 08:00AM
Jun 2, 2022 04:05PM
Jun 1, 2022 04:05PM
May 12, 2022 10:00AM
May 5, 2022 04:05PM
May 5, 2022 04:05PM GBT Announces New Employment Inducement Grants
May 4, 2022 04:05PM
Apr 28, 2022 08:20AM
Apr 27, 2022 08:00AM
Apr 7, 2022 04:05PM
Mar 29, 2022 03:17PM
Mar 24, 2022 04:05PM
Mar 23, 2022 12:45PM Guerbet: 2021 annual results
Mar 10, 2022 04:05PM

323,002 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All